SUBSTANTIAL ACQUISITION OF SHARES
Active Biotech AB´s subsidiary Movera Holding AB has acquired 909.520 B-shares in Lifco. The acquisition represents 10,0 % of the capital and 6,2 % of the votes.
As announced in the Interim Report, Active Biotech plans to offer Movera to its shareholders during this autumn. The company will be noted on the O-list of Stockholms Fondbörs.
"We see Lifco as an interesting investment. We estimate a high growth within Lifco´s sphere of activities; health food and healthcare.
Lund 7 September 1998
President, Active Biotech AB